Amit Sachdev - Feb 17, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 17, 2022
Transactions value $
-$813,087
Form type
4
Date filed
2/22/2022, 04:01 PM
Previous filing
Feb 14, 2022
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$813K -3.5K -5.92% $232.51 55.6K Feb 17, 2022 Direct
holding VRTX Common Stock 882 Feb 17, 2022 401(k)
holding VRTX Common Stock 15.6K Feb 17, 2022 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.